A recent study, touted as the largest of its kind, reveals that patients suffering from obstructive sleep apnea (OSA) experience marked improvements in sleep quality after using medical cannabis. OSA is a condition that results in repeated interruptions in breathing or shallow breathing during sleep, often due to blockages in the upper airway. This disorder not only disrupts sleep patterns and leads to fatigue but can also increase the risk of serious health issues such as high blood pressure, heart disease, and stroke.
In the United States, the prevalence of OSA is significant, affecting approximately 33.9% of men and 17.4% of women. Treatments for OSA typically include lifestyle changes, the use of devices like Continuous Positive Airway Pressure (CPAP) therapy, and in some cases, surgical interventions. However, medical cannabis has emerged as an alternative treatment option that is gaining recognition.
In Minnesota, OSA was included as a qualifying condition for medical cannabis use in 2018. The state’s medical cannabis program, initiated in 2015, has been actively collecting patient data and conducting research on the medicinal use of cannabis. The new study conducted by the Minnesota Office of Cannabis Management (OCM) assessed 3,102 OSA patients. Of the 2,749 patients who reported moderate to severe sleep disturbances, 39.4% achieved a 30% reduction in symptoms over at least four months. Additionally, among those experiencing moderate to severe fatigue, 33.5% reported a similar reduction in symptoms, also maintained for at least four months.
Adverse effects were minimal, with only 16.5% of participants reporting side effects, the majority of which were mild. The most frequently reported side effect was dry mouth, while only 3.7% experienced severe side effects, primarily fatigue and headaches. The forms of medical cannabis used varied widely among patients; inhalation products comprised 64.2% of usage, oral products such as gummies accounted for 29.2%, and oromucosal and topical products made up 4.8% and 1.9%, respectively.
As of June 2024, the OCM reported that 48,349 patients were registered in Minnesota’s medical cannabis program, with obstructive sleep apnea being the fourth most common qualifying condition. This study adds to the growing body of evidence supporting the use of medical cannabis for health conditions, particularly those like OSA that significantly impact sleep and overall well-being.
English 
Spanish 
German 
Czech